908 DEVICES INC. (MASS) Operating Margin
- Operating margin · 12 months: Value -63.99%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -63.99% | Operating income / revenue. Period ending 2026-06-30. $-38.93M ÷ $60.84M × 100 ≈ -63.99% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -38.93M USD | Operating Income (Loss) |
| Revenue | 60.84M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 14.41M USD | Research and Development Expense |
| Selling, general and administration | 38.98M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-38.93M | $60.84M | (m) | $14.41M | $38.98M | -63.99% |
| 2026-03-31 | $-41.28M | $57.80M | (m) | $15.22M | $38.20M | -71.42% |
| 2025-12-31 | $-39.42M | $56.20M | (m) | $15.57M | $38.53M | -70.15% |
| 2025-09-30 | $-78.59M | $65.05M | (m) | $26.48M | $54.35M | -120.82% |
| 2025-06-30 | $-86.75M | $65.56M | (m) | $26.85M | $54.90M | -132.33% |
| 2025-03-31 | $-80.13M | $63.99M | (m) | $26.03M | $55.67M | -125.24% |
| 2024-12-31 | $-76.72M | $59.63M | (m) | $25.50M | $53.64M | -128.65% |
| 2024-09-30 | $-66.18M | $55.16M | (m) | $24.40M | $51.76M | -119.97% |
| 2024-06-30 | $-45.05M | $52.69M | (m) | $23.15M | $49.46M | -85.51% |
| 2024-03-31 | $-42.43M | $50.73M | (m) | $22.30M | $46.07M | -83.63% |
| 2023-12-31 | $-42.76M | $50.23M | (m) | $21.90M | $46.18M | -85.13% |
| 2023-09-30 | $-43.38M | $47.52M | (m) | $21.12M | $46.23M | -91.29% |
| 2023-06-30 | $-41.45M | $49.02M | (m) | $20.25M | $46.63M | -84.55% |
| 2023-03-31 | $-38.88M | $48.03M | (m) | $19.02M | $46.14M | -80.94% |
| 2022-12-31 | $-35.38M | $46.85M | (m) | $17.53M | $43.88M | -75.52% |
| 2022-09-30 | $-28.57M | $51.05M | (m) | $16.61M | $41.20M | -55.97% |
| 2022-06-30 | $-26.69M | $47.80M | (m) | $15.24M | $38.16M | -55.85% |
| 2022-03-31 | $-25.78M | $44.97M | (m) | $14.01M | $36.23M | -57.33% |
| 2021-12-31 | $-22.07M | $42.21M | (m) | $13.07M | $32.23M | -52.29% |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $-5.82M | $26.89M | (m) | $8.23M | $12.50M | -21.62% |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |